Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/18/2025

Administering Ceftriaxone in Patients with Cephalexin Allergy

Understanding Cross-Reactivity Between Cephalosporins

  • Cross-reactivity between beta-lactam antibiotics is primarily determined by similarity in R1 side chains, not the shared beta-lactam ring structure, according to the Journal of Allergy and Clinical Immunology 2, 3
  • Cephalexin and ceftriaxone have different R1 side chains, significantly reducing the risk of cross-reactivity, as stated by the Journal of Allergy and Clinical Immunology 3

Clinical Approach Based on Reaction Type

  • Cephalosporins with dissimilar side chains can be used in patients with immediate-type allergy to another cephalosporin, regardless of severity and time since the reaction, as recommended by Clinical Microbiology and Infection 4
  • A meta-analysis of clinical studies showed that ceftriaxone can be safely administered to patients with allergies to cephalosporins with different side chains, according to the Journal of Allergy and Clinical Immunology 2
  • Patients with non-severe, delayed-type allergy to a cephalosporin can receive other cephalosporins with dissimilar side chains, as stated by Clinical Microbiology and Infection 1

Implementation Considerations

  • Even with low cross-reactivity risk, administer the first dose of ceftriaxone in a setting where allergic reactions can be promptly managed, as recommended by the Journal of Allergy and Clinical Immunology 2
  • If there is high concern about potential cross-reactivity, consider alternative options such as Aztreonam, which has negligible cross-reactivity with cephalosporins except ceftazidime and cefiderocol, as stated by Clinical Microbiology and Infection 1, 4
  • Carbapenems can be safely used in patients with cephalosporin allergy, according to Clinical Microbiology and Infection 4